URAC’s New Specialty and Mail Service Pharmacy Accreditation Standards, v. 5.0: Part 7
(Patient Service & Communication)

In October 2022, URAC unveiled the new Specialty Pharmacy and Mail Service Pharmacy Accreditation Programs, v. 5.0. In this video, the seventh of a series of eight videos, we explore what’s new as it relates to the Patient Service and Communication (“P-PSC”) module within those two accreditation programs.

In this educational video, IHS's CEO, Dr. Tom Goddard, sits down with the company's Chief Operating Officer and Senior Pharmacy Consultant, Dr. Jill Paslier, to discuss the changes in the URAC Specialty Pharmacy and Mail Service Pharmacy accreditation standards between version 4.0 and version 5.0.

Jill shares her insights and expertise on the updated standards, highlighting the key changes that impact specialty and mail service pharmacies seeking URAC accreditation. She also offers practical advice on how specialty pharmacies can ensure they meet the new requirements and maintain their accreditation status.

Whether you are a specialty or mail service pharmacy owner, operator, or clinician, this video is a must-watch. You'll gain valuable knowledge and a deeper understanding of the URAC Specialty Pharmacy and Mail Service Pharmacy accreditation standards and what it takes to achieve and maintain accreditation in today's healthcare landscape.

So, sit back, relax, and get ready to learn from the experts at IHS!

Topics covered include:

  • Patient Service and Communication

  • Patient Satisfaction

  • Prescriber Satisfaction

  • Accommodating Diverse Populations

  • Patient's Preferred Outreach Method

 

Transcription

[00:00:22.840] - Tom Goddard

Couple of minor changes in P-PSC, right?

 

[00:00:26.920] - Jill Paslier

Yeah, so we can go over that section. Let's see here. There is a new leading indicator in one of the sections talking about patient communication and accommodating diverse populations. Some of the verbiage is the same, but the new leading indicator is about accommodating the patient's preferred outreach method. Just having a way to determine what that is and to adapt to the patient's preferred method. That's a leading indicator. Then in the telephone performance section, they've updated the definition of abandonment rate in the interpretive information. It's probably similar to what you've been doing already and how you've been measuring this, but I just want to make sure that you look at that change in the details just to make sure that you're defining abandonment rate the same way that URAC wants you to define it.

 

[00:01:20.740] - Tom Goddard

Great. Yeah, that was always... I think most of our clients settled on an appropriate way to measure abandonment rate, but there was some confusion when that first came out, and so I'm glad to see that that's further clarified.